#ADA26: AstraZeneca GLP-1 pill cuts weight 10.5% after six monthsnews2026-06-08T20:15:05+00:00June 8th, 2026|Endpoints News|
Incyte CEO sees $2B Vega deal aiding a post-Jakafi futurenews2026-06-08T19:01:18+00:00June 8th, 2026|Endpoints News|
City Therapeutics gets $99M to gather data on three RNAi medicinesnews2026-06-08T18:26:40+00:00June 8th, 2026|Endpoints News|
GoHealth files for bankruptcy, as Medicare Advantage insurers pull backnews2026-06-08T16:46:03+00:00June 8th, 2026|Endpoints News|
Treeline to go public via reverse merger with Standard BioToolsnews2026-06-08T15:16:35+00:00June 8th, 2026|Endpoints News|
J&J makes $1B move for Firefly Bio, Carolyn Bertozzi’s twist on ADCs in KRAS fieldnews2026-06-08T14:53:00+00:00June 8th, 2026|Endpoints News|
GSK inks multi-target pact with Engitix; Sangamo considers strategic optionsnews2026-06-08T14:17:48+00:00June 8th, 2026|Endpoints News|
Tango plans Phase 3 pancreatic cancer study after combo successnews2026-06-08T14:07:54+00:00June 8th, 2026|Endpoints News|
Biopharma’s top-paid CEOs of 2025: 25 making $25M+ news2026-06-08T14:00:45+00:00June 8th, 2026|Endpoints News|
